These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long noncoding RNAs in the mTOR signaling network: biomarkers and therapeutic targets. Huang T; Wang M; Huang B; Chang A; Liu F; Zhang Y; Jiang B Apoptosis; 2018 Jun; 23(5-6):255-264. PubMed ID: 29556906 [TBL] [Abstract][Full Text] [Related]
4. Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review). Fan H; Wu Y; Yu S; Li X; Wang A; Wang S; Chen W; Lu Y Int J Oncol; 2021 Jan; 58(1):9-19. PubMed ID: 33367927 [TBL] [Abstract][Full Text] [Related]
5. Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer. Zeng JD; Wu WKK; Wang HY; Li XX Pharmacol Res; 2019 Nov; 149():104352. PubMed ID: 31323332 [TBL] [Abstract][Full Text] [Related]
6. mTOR signaling in the differentiation and function of regulatory and effector T cells. Zeng H; Chi H Curr Opin Immunol; 2017 Jun; 46():103-111. PubMed ID: 28535458 [TBL] [Abstract][Full Text] [Related]
7. mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro. Ayuk SM; Abrahamse H Cells; 2019 May; 8(5):. PubMed ID: 31075885 [TBL] [Abstract][Full Text] [Related]
8. mTOR at the Transmitting and Receiving Ends in Tumor Immunity. Guri Y; Nordmann TM; Roszik J Front Immunol; 2018; 9():578. PubMed ID: 29662490 [TBL] [Abstract][Full Text] [Related]
9. [TOR-centric concept of regulation mitogenic, metabolic and energetic signal processing in cell]. Zubova SG; Shitikova ZhV; Pospelova TV Tsitologiia; 2012; 54(8):589-602. PubMed ID: 23074850 [TBL] [Abstract][Full Text] [Related]
10. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance. Ediriweera MK; Tennekoon KH; Samarakoon SR Semin Cancer Biol; 2019 Dec; 59():147-160. PubMed ID: 31128298 [TBL] [Abstract][Full Text] [Related]
11. mTOR: Role in cancer, metastasis and drug resistance. Murugan AK Semin Cancer Biol; 2019 Dec; 59():92-111. PubMed ID: 31408724 [TBL] [Abstract][Full Text] [Related]
12. PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer. Marquard FE; Jücker M Biochem Pharmacol; 2020 Feb; 172():113729. PubMed ID: 31785230 [TBL] [Abstract][Full Text] [Related]
14. Targeting mTOR and Metabolism in Cancer: Lessons and Innovations. Magaway C; Kim E; Jacinto E Cells; 2019 Dec; 8(12):. PubMed ID: 31817676 [TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects. Cai H; Dong LQ; Liu F Trends Pharmacol Sci; 2016 Apr; 37(4):303-317. PubMed ID: 26700098 [TBL] [Abstract][Full Text] [Related]
16. Advances in understanding the mechanisms of evasive and innate resistance to mTOR inhibition in cancer cells. Chiarini F; Evangelisti C; Lattanzi G; McCubrey JA; Martelli AM Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1322-1337. PubMed ID: 30928610 [TBL] [Abstract][Full Text] [Related]
17. mTOR signaling pathway and mTOR inhibitors in cancer therapy. Gomez-Pinillos A; Ferrari AC Hematol Oncol Clin North Am; 2012 Jun; 26(3):483-505, vii. PubMed ID: 22520976 [TBL] [Abstract][Full Text] [Related]
18. Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer. Bitting RL; Armstrong AJ Endocr Relat Cancer; 2013 Jun; 20(3):R83-99. PubMed ID: 23456430 [TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases. Kaur A; Sharma S Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246 [TBL] [Abstract][Full Text] [Related]
20. Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer. Evangelisti C; Chiarini F; Paganelli F; Marmiroli S; Martelli AM Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118635. PubMed ID: 31884070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]